AF
BIO icon

Allworth Financial’s Bio-Rad Laboratories Class A BIO Stock Holding History

Allworth Financial’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.3K Sell
52
-31
-37% -$8.79K ﹤0.01% 3409
2026
Q1 		$23.1K Buy
83
+31
+60% +$8.93K ﹤0.01% 2886
2025
Q4 		$15.8K Sell
52
-12
-19% -$3.74K ﹤0.01% 2965
2025
Q3 		$17.9K Buy
64
+18
+39% +$4.9K ﹤0.01% 2771
2025
Q2 		$11.1K Sell
46
-98
-68% -$23.2K ﹤0.01% 2843
2025
Q1 		$36K Buy
144
+104
+260% +$31.3K ﹤0.01% 1728
2024
Q4 		$14.4K Buy
40
+1
+3% +$339 ﹤0.01% 2298
2024
Q3 		$13K Sell
39
-6
-13% -$1.91K ﹤0.01% 2145
2024
Q2 		$13.4K Sell
45
-12
-21% -$3.49K ﹤0.01% 2102
2024
Q1 		$19.7K Buy
57
+11
+24% +$3.62K ﹤0.01% 1782
2023
Q4 		$14.9K Sell
46
-35
-43% -$11K ﹤0.01% 1809
2023
Q3 		$29K Buy
81
+10
+14% +$3.86K ﹤0.01% 1322
2023
Q2 		$26.9K Sell
71
-22
-24% -$8.95K ﹤0.01% 1368
2023
Q1 		$44.5K Buy
93
+37
+66% +$17.3K ﹤0.01% 1110
2022
Q4 		$23.5K Sell
56
-83
-60% -$33.5K ﹤0.01% 1285
2022
Q3 		$58K Buy
139
+112
+415% +$55.8K ﹤0.01% 906
2022
Q2 		$13K Buy
27
+25
+1,250% +$13K ﹤0.01% 1426
2022
Q1 		$1K Sell
2
-22
-92% -$13.3K ﹤0.01% 1882
2021
Q4 		$18K Buy
+24
New +$18K ﹤0.01% 1154
2021
Q2 		– Sell
-70
Closed -$40K – 1550
2021
Q1 		$40K Hold
70
– – ﹤0.01% 617
2020
Q4 		$41K Hold
70
– – ﹤0.01% 514
2020
Q3 		$36K Hold
70
– – ﹤0.01% 467
2020
Q2 		$32K Hold
70
– – ﹤0.01% 491
2020
Q1 		$25K Hold
70
– – ﹤0.01% 523
2019
Q4 		$26K Buy
+70
New +$24.7K ﹤0.01% 472

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Allworth Financial's BIO Position: Q2 2026 in Review

Allworth Financial reduced its Bio-Rad Laboratories Class A (BIO) stake by 37% in Q2 2026, selling an estimated $8.79K and leaving 52 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3409.

Allworth Financial first reported a position in BIO in Q4 2019 and has held it in 25 quarters since. The position peaked at $58K in Q3 2022. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Allworth Financial held 52 shares of Bio-Rad Laboratories Class A worth $15.3K as of Q2 2026.
  • Allworth Financial sold 31 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $8.79K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3409 holding.
  • Allworth Financial first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and has held it in 25 quarters since.
  • Allworth Financial's Bio-Rad Laboratories Class A position peaked at $58K in Q3 2022.
  • 400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.